Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × OTHER × Glioblastoma × Clear all

Status

Completed 463 Recruiting 183 Terminated 126 Unknown 119 Active not recruiting 93 Withdrawn 58 Not yet recruiting 54 Suspended 9 Enrolling by invitation 4 No longer available 2 Available 1

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Neuroblastoma 4 Recurrence 3 Prostatic Neoplasms 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive 2 Insulinoma 2 Immunologic Deficiency Syndromes 2 Hypoglycemia 2 Hyperinsulinism 2 Hematologic Neoplasms 2 Typical Teratoid Rhabdoid Tumor 1 Triple Negative Local Advanced Breast Cancer 1 Thyroid Nodule 1 Thalassemia 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pheochromocytoma 1 Parathyroid Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oncology Patients With Gastroparesis 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metabolic Diseases 1 Medulloblastoma 1 Lymphoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06676891 2025-01-08

Expanded Access Program for GBM Subjects

Rznomics, Inc.

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡